Aminediol protease inhibitors

Details Aminediol protease inhibitors Aminediol protease inhibitors

1995-05-31

1998-06-02

Ramsuer, Robert W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514330, 544168, 546226, A61K 31445, A61K 31535, C07D295192

Patent

active

057600368

ABSTRACT:
Novel aminediol compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds in inhibiting retroviral protease, particularly useful in the treatment and/or prevention of HIV infection (AIDS).

REFERENCES:
patent: 2046720 (1936-07-01), Bottoms
patent: 2715631 (1955-08-01), Croxall et al.
patent: 4483850 (1984-11-01), Patchett et al.
patent: 4528282 (1985-07-01), Preston et al.
patent: 4602002 (1986-07-01), Patchett et al.
patent: 4644055 (1987-02-01), Kettner et al.
patent: 4665055 (1987-05-01), Evans
patent: 4719288 (1988-01-01), Fuhrer et al.
patent: 4727060 (1988-02-01), Buhlmayer et al.
patent: 4855286 (1989-08-01), Wagner et al.
patent: 5098924 (1992-03-01), Poss
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5157041 (1992-10-01), Handa et al.
patent: 5169952 (1992-12-01), Askin et al.
patent: 5196438 (1993-03-01), Martin et al.
Annual Drug Data Report, p. 801 (1987).
Billich et al., Arch. of Biochem. and Biophys., 290, pp. 186-190 (19910.
Blumenstein, et al., Synthetic Non-Peptide Inhibitors of HIV Protease; Biochemical and Biophysical Research Communications; vol. 163, No. 2, pp. 980-987 (1989).
Bone, et al., X-ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C.sub.2 Symmetry; J. Am. Chem. Soc., 113, pp. 9382-9384 (1991).
Chenera, et al., Syntheis of C.sub.2 -Symmetric and Pseudosymmetric HIV-1 Protease Inhibitors from D-Mannitol and D-Arabitrol; Bioorganic & Medicinal Chemistry Letters, vol 1, No. 4, pp. 219-222 (1991).
Connolly, et al., Antiretroviral Therapy: Strategies Beyond Single-Agent Reverse Transcriptase Inhibition; Antimicrobial Agents and Chemotherapy, vol. 36, No. 3, pp. 509-520 (1992).
Copeland, et al., Substitution of Proline with Pipecolic Acid at the Scissile Bond Converts a Peptide Substrate of HIV Proteinase Into A Selective Inhibitor; Biochemical and Biophysical Research Communications; vol. 169, No. 1, pp. 310-314 (1990).
DeCamp, et al., Specific Inhibition of HIV-1 Protease by Boronated Porphyrins; J. Med. Chem., 35, pp. 3426-3428 (1992).
DesJarlais, et al., Structure-based Design of Nonpeptide Inhibitors Specific for the Human Immunodeficiency Virus 1 Protease; Proc. Natl. Acad. Sci., vol. 87, pp. 6644-6648 (1990).
deSolms, et al., Design and Synthesis of HIV Protease Inhibitors. Variations of the Carboxy Terminus of the HIV Protease Inhibitors L-682,679; J. Med. Chem., 34, pp. 2852-2857 (1991).
Dombrowski, et al., L-696,474, A Novel Cytochalasin as an Inhibitor of HIV-1 Protease 1. The Producing Organism and its Fermentation; J. of Antibiotics, vol. 45, No. 5, p. 671 (1992).
Dryer, et al., Hydroxyethylene Isostere Inhibitors of Human Immunodeficiency Virus-1 Protease: Structure-Activity Analysis Using Enzyme Kinetics, X-ray Crystallography, and Infected T-Cell Assays; Biochemistry, 31, pp. 6646-6659 (1992).
Dreyer, et al., Inhibition of Human Immunodeficiency Virus 1 Protease In vitro: Rational design of substrate analogue inhibitors; Proc. Natl. Acad. Sci., vol. 86, 1989; pp. 9752-9756 (1989).
Dwyer, et al., Amino Hemiketal Inhibitors of Aspartic Proteases, No. 11, American Chemical Society Meeting, San Francisco (Mar., 1992), abstract handout (2 pages).
Erickson, et al., Design, Activity and 2.8 A Crystal Structure of a C.sub.2 Symmetric Inhibitor Complexed to HIV-1 Protease; Science, vol. 249, pp. 527-533 (1990).
Ghosh, et al., Stereocontrolled Synthesis of HIV-1 Protease Inhibitors with C.sub.2 -Axis of Symmetry; Tetrahedron Letters, vol. 32, No. 41, pp. 5729-5732 (1991).
Goldman et al., L-696,229 Specifically Inhibits Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Possesses Antiviral Activity In Vitro, Antimicrobial Agents and Chemotherapy, pp. 1019-1023 (1992) (abstract only).
Grobelny, et al., Selective Phosphinate Transition-State Analogue Inhibitors of the Protease of Human Immunodeficiency Virus; Biochemical and Biophysical Research Communications; vol. 169, No. 3, pp. 1111-1116 (1990).
Hui, et al., A Rational Approach in the Search for Potent Inhibitors Against HIV proteinase; The FASEB Journal, vol. 5, pp. 2606-2610 (1991).
Humber, et al., Penicillin Derived C.sub.2 -Symmetric Dimmers as Novel Inhibitors of HIV-1 Proteinase, J. Med. Chem., 35, pp. 3080-3081 (1992). Replacement: Potent Slow-Binding Inhibition of the HIV Protease, J. Am. Chem. Soc., 114, pp. 7604-7606 (1992).
Kahn, et al., Examination of HIV-1 Protease Secondary Structure Specificity Using Conformationally Constrained Inhibitors; J. Med. Chem., 34, pp. 3395-3399 (1991).
Kempf, et al., Structure-Based, C.sub.2 Symmetric Inhibitors of HIV Protease; J. Med. Chem., 33, pp. 2687-2689 (1990).
Kempf, et al., Antiviral and Pharmacokinetic Properties of C.sub.2 Symmetric Inhibitors of the Human Immunodeficiency Virus Type 1 Protease; Antimicrobial Agents and Chemotherapy, vol. 35, No. 11, pp. 2209-2214 (1991).
Korant, et al., Virus-specified protease in poliovirus-infected HeLa cells; Proc. Natl. Acad. Sci. USA, vol. 76, No. 6, pp. 2992-2995 (1979).
Kotler, et al., Synthetic Peptides as Substrates and Inhibitors of a Retroviral Protease; Proc. Natl. Acad. Sci., vol. 85, pp. 4185-4189 (1988).
Krohn, et al., Novel Binding Mode of Highly Potent HIV-Proteiinase Inhibitors Incorporating the (R)-Hydroxyethylamine Isostere; J. Med. Chem., 34, pp. 3340-3342 (1991).
Lambert, et al., Human Immunodeficiency Virus Type 1 Protease Inhibitors Irreversibly Block Infectivity of Purified Virions from Chronically Infected Cells; Antimicrobial Agents and Chemotherapy, pp. 982-988 (1992) (abstract only).
Lingham, et al., HIV-1 Protease Inhibitory Activity of L-694,746, A Novel Metabolite of L-689,502; Biochemical and Biophysical Research Comm., vol. 181, No. 3, pp. 1456-1461 (1991).
Lingham, et al., L-696,474, A Novel Cytochalasin as an Inhibitor of HIV-1 Proteae III. Biological Acitivity; J. of Antibiotics, p. 686 (1992).
Lyle, et al., Benzocycloalkyl Amines as Novel C-Termini for HIV Protease Inhibitors; J. Med. Chem., 34, pp. 1228-1230 (1991).
McLeod, et al., Phosphonamidates and Phosphonamidate Esters as HIV-1 Protease Inhibitors; Bioorganic & Medicinal Chemistry Letters, vol. 1, No. 11, pp. 653-658 (1991).
Mimoto, et al., KNI-102 A Novel Tripeptide HIV Protease Inhibitor containing Allophenylnorstatine as a Transition-State Mimic; Chem. Pharm. Bull. vol. 39, No. 11, pp. 3088-3090 (1991).
Mimoto, et al., Rational Design and Synthesis of a Novel Class of Active Site-Targeted HIV Protease Inhibitors Containing a Hydroxymethylcarbonyl Isostere. Use of Phenylnorstatine or Allophenylnorstatine as a Transition-State Mimic; Chem. Pharm. Bull. vol. 39, No. 9, pp. 2465-2467 (1991).
Moore, et al., Peptide Substrates and Inhibitors of the HIV-1 Protease; Biochemical and Biophysical Research Communications; vol. 195, No. 2, pp. 420-425 (1989).
Ondeyka, et al., L-696,474, A Novel Cytochalasin as an Inhibitor of HIV-1 Protease II. Isolation and Structure; J. of Antibiotics, vol. 45, No. 5, p. 679 (1992).
Owens, et al., The Rapid Identification of HIV Protease Inhibitors Through the Synthesis and Screening of Defined Peptide Mixtures; Biochemical and Biophysical Research Communications; vol. 181, no. 1, pp. 402-408 (1991).
Peyman, et al., C.sub.2 -Symmetric Phosphinic Acid Inhibitors of HIV Protease; Tetrahedron Letters, vol. 33, No. 32, pp. 4549-4552 (1992).
Raju, et al., Substrate Analog Inhibitors of HIV-1 Protease Containing Phenylnorstatine as a Transition State Element; Biochemical and Biophysical Research Communications; vol. 180, No. 1, pp. 181-186 (1991).
Raju, et al., Investigating the Stereochemistry of Binding to HIV-1 Protease with Inhibitors Containing Isomers of 4-Amino-3-hydroxy-5-phenylpentanoic Acid, Biochemical and Biophysical Research Communications, vol. 180, No. 1, pp. 187-190 (1991).
Rich, et al., Hydroxyethylamine Analogues of the p17/;24 Substrate Cleavage Site Are Tight-Binding Inhibitors of HIV Protease; J. Med. Chem., 33, pp. 1285-1288 (1990).
Rich, et al., Effect of Hydroxyl Group Configuration in Hydroxyethylamine Dipeptide Isosteres on HIV Protease Inhibition. Evidence for Mult

Affiliated with

Also associated with

Rating

Aminediol protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminediol protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminediol protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1460044